Literature DB >> 28906004

Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.

Nathalie Douet-Guilbert1,2,3, Aurelie Chauveau4, Nadia Gueganic1,2, Gaëlle Guillerm5, Corine Tous3, Marie-Josee Le Bris3, Audrey Basinko2,3, Frederic Morel1,2,3, Valerie Ugo1,4, Marc De Braekeleer1,2,3.   

Abstract

Inv(16)(p13q22) and t(16;16)(p13;q22) are cytogenetic hallmarks of acute myelomonoblastic leukaemia, most of them associated with abnormal bone marrow eosinophils [acute myeloid leukaemia French-American-British classification M4 with eosinophilia (FAB AML-M4Eo)] and a relatively favourable clinical course. They generate a 5'CBFB-3'MYH11 fusion gene. However, in a few cases, although RT-PCR identified a CBFB-MYH11 transcript, normal karyotype and/or fluorescent in situ hybridization (FISH) analyses using commercially available probes are found. We identified a 32-year-old woman with AML-M4Eo and normal karyotype and FISH results. Using two libraries of Bacterial Artificial Chromosome clones on 16p13 and 16q22, FISH analyses identified an insertion of 16q22 material in band 16p13, generating a CBFB-MYH11 type A transcript. Although very rare, insertions should be searched for in patients with discordant cytological and cytogenetic features because of the therapeutic consequences.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  acute myelomonoblastic leukaemia; chromosome 16; insertion

Mesh:

Substances:

Year:  2015        PMID: 28906004     DOI: 10.1002/hon.2268

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  2 in total

1.  MicroRNA-31 is a potential biomarker for screening B-lymphoblastic leukemia in children.

Authors:  Yan Zhang; Xin Li; Liping Bai; Li Li; Danhong Li; Xue Ding; Bo Wang; Chengwei Li
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

2.  The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis.

Authors:  Wen-Ting Zhang; Guo-Xun Zhang; Shuai-Shuai Gao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.